Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Diabetes and Drug Treatments
TYPE II DIABETES AND DRUG TREATMENTS
Differences
Type I Diabetes
Diabetes mellitus type 1 result from autoimmune destruction of insulin-producing beta cells within the pancreas. Subsequent shortage of insulin translates to increased urine and blood glucose. The developed world is associated with increasingly variant type I diabetes with a large cause of kidney failure and non-traumatic blindness. The link is based on an increased dementia and cognitive dysfunction risk through disease processes of vascular dementia and Alzheimer's disease. The complications are inclusive of sexual dysfunction, acanthosis nigricans, and frequent infections (Jones, et al., 2012).
Type II Diabetes
The classic diabetes symptoms include polyuria (frequent urination), increased thirst, increased hunger (polyphagia), and weight loss. Alternative symptoms commonly presented in the diagnosis include histories of blurred vision, fatigue, recurrent vaginal infections, peripheral neuropathy, and itchiness (Barnett, 2012). However, many people lack symptoms in the initial years and while the diagnosis is presented to routine testing. People suffering from type II diabetes mellitus rarely present hyperosmolar hyperglycemic states that are conditions of high blood sugar linked to low blood pressure and decreased the level of consciousness (Thomas, 2015).
Gestational Diabetes
Gestational diabetes is seen...
The gestational diabetes impacts on how the cells utilize sugar (glucose). Gestational diabetes leads to high blood sugar affecting a pregnancy and baby's health. The scope of gestational diabetes includes blood sugar returning to normal after delivery. Gestational diabetes infects the ten-year-shorter life expectancies. This is mainly due to the scope of complications that are associated with risks of cardiovascular diseases of including ischemic stroke and heart disease (Pereira, 2013).
Juvenile Diabetes
Juvenile diabetes involves short-acting insulin action through an onset of between 30 minutes and peak action of 4 hours. The intermediate action of insulin onsets in 2 hours. Long-acting insulin is given at bedtime. The action onset is roughly 1 to 2 hours with a sustained action of 24 hours. Juvenile diabetes occurs when beta cells produce insufficient insulin resulting in eventual insulin resistance. Insulin resistance linked to the inabilities of cells to respond adequately to normal insulin levels primarily occurs in the liver, fat tissue, and muscles. The liver shows insulin's normal suppression of glucose release. However, the insulin resistance setting in the liver is inappropriately released through glucose to the blood (Ezrin, & Kowalski, 2011).
Diabetes type II
Diabetes mellitus type II is defined as one of the metabolic disorders characterized by high blood sugar or hyperglycemia in…
References
Barnett, A. (2012). Type II Diabetes. New York: OUP Oxford.
Ezrin, C. & Kowalski, R. (2011). The Type 2 Diabetes Diet Book, Fourth Edition. McGraw Hill Professional
Jones, R. M. et al., (2012). New Therapeutic Strategies for Type 2 Diabetes: Small Molecule Approaches. New York: Royal Society of Chemistry
Pereira, M. A. (2013). Nutrition and Type II Diabetes: Etiology and Prevention. New York: CRC Press.
Diabetes II Description of the Client Situation: This case examines Type II Diabetes in a 45-year-old black woman, an immigrant from Africa and a high school graduate, whose husband died a year ago. She is a restaurant manager and has a health insurance plan as one of the benefits offered by her employer. Her vision is slightly impaired but that does not concern her much, because with glasses her sight is almost
Diabetes Mellitus Type II Diabetes is described as a condition that results from a chronic problem of hyperglycaemia that is brought about by insulin inaction in the body system. Diabetes type II is a condition that fronts the case for a range of diabetic problems characterised by some pathophysiological symptoms, including increased insulin resistance and impaired insulin secretion. The problems observed in the cell function and the deteriorating pancreatic conditions
Background Patient V.G., a 47 year old African American male, was diagnosed two years ago with type II diabetes. During a follow up, the patient complained of increased tingling in lower extremities. His medical history shows high or abnormal cholesterol levels (dyslipidemia, hypertension (HTN), obesity, and former smoking habits (stopped 2 years ago). He has no declared history of alcohol use. Living alone in subsidized housing and relying on food stamps
Some patients feel helpless, hopeless, depressed, isolated from others, belittled, and do not know how to seek appropriate help from others (Rutter 2004). Socially supportive arrangements were addressed as the attributes of socially legitimate roles which provide for the meeting dependency needs without loss of esteem. Socially supportive environments were presented as pattern interpersonal relationships mediated through shared values and sentiments as well as facilitate the performance of social
Diabetes and Obesity: What Are the Choices? Diabetes is becoming an increasingly serious health problem across the United States, and indeed across the world. The majority of cases of diabetes, both in terms of new diagnoses and of current cases, are those of Type II diabetes, which is a condition generally brought on by overweight or obesity and lack of exercise, that prevents an individual's body from being able to metabolize
Diabetic Intervention Planning The intervention plan that I would create and attempt to implement to address the health promotion issue of Type 2 diabetes is one that is fairly standard for treating this malady. Quite simply, it would involve patients monitoring their blood sugar levels multiple times a day. Additionally, it would also require their self-administration of insulin (Ehrlich, 2013) in order to maintain patient-specific targets for their blood glucose